24-Hour Blood Pressure Variability Linked to Cognitive Decline and Brain Aging

Beyond Mean Values in Hypertensive Brain Health

Hypertension remains a primary modifiable risk factor for the development of cerebral small vessel disease and subsequent cognitive impairment [1, 2]. While intensive blood pressure control targeting a systolic pressure below 120 mmHg has demonstrated efficacy in slowing the progression of white matter hyperintensities (standardized mean difference = -0.33, 95% CI: -0.44 to -0.21), its impact on overall cognitive preservation remains inconsistent across major clinical trials [1, 3]. Meta-analytic data involving 2,891 participants indicate that intensive therapy does not significantly alter cognitive function scores (standardized mean difference = -0.08, 95% CI: -0.23 to 0.06) compared to standard treatment [1]. Current management guidelines emphasize achieving specific systolic and diastolic targets to mitigate cardiovascular and cerebrovascular morbidity [4, 5]. However, these static measurements may overlook the physiological impact of blood pressure instability, which is increasingly recognized as a contributor to end-organ damage [6, 7]. A new study now examines how 24-hour fluctuations in pressure influence structural brain integrity and cognitive performance in older adults, suggesting that variability itself may be an independent driver of neurodegeneration.

Ambulatory Monitoring and Multimodal Neuroimaging

To investigate the relationship between 24-hour blood pressure variability, cognitive performance, and structural brain health, researchers analyzed data from 225 dementia-free participants in the community-based Brain and Cognitive Health (BACH) study in Melbourne, Australia. This primary cohort had a mean age of 67 years and was 51% female. The study utilized 24-hour ambulatory blood pressure monitoring alongside traditional office measurements, blood collection, and neuropsychological testing. The primary metric for blood pressure variability was the coefficient of variation (a statistical measure that expresses the standard deviation as a percentage of the mean, capturing relative fluctuations), which was calculated for 24-hour, awake, and asleep periods.

Neuroimaging assessments focused on both established and advanced structural markers. The researchers measured white matter hyperintensities, brain volumetrics, and cerebral blood flow. To evaluate more subtle physiological changes, they employed advanced MRI techniques including white matter free water (a measure of extracellular fluid that can indicate neuroinflammation or edema) and diffusion along the perivascular space (a proxy for the brain's glymphatic clearance system, which removes metabolic waste). They also assessed the blood-brain barrier water exchange rate (k_w), a specific imaging marker of barrier integrity. The primary outcomes for the analysis were global cognition and white matter hyperintensity volume, providing a dual focus on clinical function and structural pathology.

To validate these findings, the authors sought a partial replication in the HYpertension and gut PERmeability (HYPER) study. This secondary cohort consisted of 76 participants aged 27 to 73 years with a median age of 63 years and a 50% female distribution. While the BACH study used traditional neuropsychological testing, the HYPER study assessed cognition via the digital NIH Toolbox. For both cohorts, the researchers utilized linear regressions adjusted for demographic and vascular risk factors. In these models, the statistical coefficients (β) represented the standard deviation change in the specific outcome per standard deviation increase in blood pressure exposure, allowing for a standardized comparison of how hemodynamic fluctuations impact brain health.

Cognitive Deficits and White Matter Integrity

The researchers evaluated cognitive performance by calculating composite scores for global cognition, which provides a broad overview of mental status, and executive function, which reflects higher-level processes such as planning and cognitive flexibility. In the primary BACH cohort, higher 24-hour blood pressure variability was associated with poorer global cognition (β = -0.152, 95% CI -0.278 to -0.027). This relationship remained consistent during active periods, as higher awake blood pressure variability also correlated with lower global cognitive scores (β = -0.158, 95% CI -0.285 to -0.031). For practicing physicians, these findings suggest that the degree of fluctuation in blood pressure throughout the day may be as clinically relevant to a patient's cognitive trajectory as their absolute pressure levels.

The impact of blood pressure instability extended specifically to executive function, a domain often sensitive to vascular-related brain changes. The study found that higher 24-hour blood pressure variability was associated with poorer executive function (β = -0.174, 95% CI -0.299 to -0.049). Similarly, increased awake blood pressure variability was linked to diminished executive performance (β = -0.168, 95% CI -0.294 to -0.042). While variability influenced cognitive output, the structural burden of cerebral small vessel disease was more closely tied to average pressure levels. Specifically, mean 24-hour blood pressure was positively associated with white matter hyperintensity burden (β = 0.182, 95% CI 0.047 to 0.316, n = 217), indicating that chronic pressure elevation drives visible structural damage in the white matter.

To strengthen these observations, the researchers examined the HYPER study for replication. In this secondary cohort, asleep blood pressure variability was negatively associated with fluid cognition (β = -0.211, 95% CI -0.382 to -0.040). Fluid cognition refers to the capacity to solve new problems, use logic in novel situations, and identify patterns. This finding highlights that blood pressure fluctuations occurring during rest may be particularly detrimental to the processing speed and reasoning abilities of older adults, further reinforcing the link between hemodynamic instability and accelerated cognitive decline.

Blood-Brain Barrier Leakage and Genetic Vulnerability

The physiological mechanisms linking blood pressure fluctuations to cognitive decline may involve the microvascular integrity of the central nervous system. The researchers investigated how these fluctuations impact the blood-brain barrier, the highly selective semipermeable border that prevents circulating solutes from non-selectively crossing into the brain's extracellular fluid. In a sub-analysis of 213 participants, higher blood pressure variability was negatively associated with the blood-brain barrier water exchange rate (k_w) (β = -0.180, 95% CI -0.314 to -0.045). Because this water exchange rate serves as a sensitive marker of barrier integrity, a lower rate suggests a compromised or leaky barrier. Clinically, this indicates that hemodynamic instability may contribute to the breakdown of the blood-brain barrier, potentially allowing neurotoxic substances to enter the brain parenchyma and accelerate neurodegenerative processes.

The study further explored whether genetic factors influence the brain's susceptibility to these pressure fluctuations. Specifically, the researchers investigated whether these associations were modified by APOE ε4 status, a major genetic risk factor for Alzheimer's disease. The data revealed a significant interaction between genetics and vascular health: 24-hour blood pressure variability was positively associated with white matter hyperintensity volume specifically among APOE ε4 carriers. White matter hyperintensities are areas of high signal intensity on MRI that represent small vessel disease, axonal loss, and demyelination. While mean blood pressure typically drives these lesions in the general population, this finding suggests that individuals carrying the ε4 allele may have a unique vulnerability to the mechanical stress caused by fluctuating blood pressure, leading to greater structural damage.

Collectively, the evidence demonstrates that higher blood pressure variability was associated with compromised blood-brain barrier integrity and poorer global cognition and executive functioning. For the practicing clinician, these results suggest that 24-hour ambulatory monitoring may provide critical prognostic information that office-based measurements miss. Because elevated blood pressure variability appears to be a risk factor for accelerated brain aging, particularly in APOE ε4 carriers, stabilizing these fluctuations could represent a distinct therapeutic target for preserving cognitive health in older adults. The correlation between blood-brain barrier leakage and blood pressure instability provides a plausible biological pathway for how erratic systemic hemodynamics translate into measurable cognitive deficits and structural brain injury.

References

1. Liao Z, Cheng L, Wang Y, Yang Y, Lv X, Gu P. Intensive Antihypertensive Treatment and Cerebral Small Vessel Disease: A Systematic Review and Meta-Analysis of Randomised Clinical Trials. European Neurology. 2025. doi:10.1159/000547434

2. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal. 2018. doi:10.1093/eurheartj/ehy339

3. Group TSR. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. New England Journal of Medicine. 2015. doi:10.1056/nejmoa1511939

4. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. European Heart Journal. 2013. doi:10.1093/eurheartj/eht151

5. Visseren FL, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal. 2021. doi:10.1093/eurheartj/ehab484

6. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2020. doi:10.1093/eurheartj/ehaa612

7. Collet J, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal. 2020. doi:10.1093/eurheartj/ehaa575